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To explore the integration and delivery of oncology led referrals to palliative care (PC) by examining physician 
attitudes and referral practices. 
Methods 
An online survey was circulated to oncologists and PC physicians in Ireland.  
Results 
The study (N = 100) comprised sixty-nine oncologists (69%) and thirty-one PC physicians (31%). Ninety-two(92%) 
believe patients with advanced cancer should receive concurrent treatment, however only 53% of oncologists(N = 
37) routinely refer. Regarding end-of-life (EOL) care: 81% of oncologists (N = 55) are directly involved in its 
administration, despite 84% (N = 53) agreeing patients benefit when PC specialists coordinate EOL care. 
Conclusion 
The gulf between positive attitudes and limited implementation suggests the need for interdisciplinary changes to 
facilitate integration of PC in clinical practice in Ireland.  
 
      
Introduction 
 
Research confirms the integration of PC for patients with advanced disease, which is delivered concurrently with 
oncology treatment intended to prolong life, has the potential to improve clinical outcomes 1, 2. Most notably Temel 
et al. illustrated that introducing PC at diagnosis of advanced cancer led to longer median survival rates, less 
symptom burden, better quality of life, better understanding of prognosis, less anxiety and depression, and less 
aggressive end-of-life care 2. This practice changing study resulted in revision of oncology guidelines to recommend 
the early incorporation of PC input 3. 
 
Studies on oncologist perceptions and referral practices have demonstrated the majority of oncologists describe 
their view of PC as favourable. Realising the benefits most oncologists would prefer an integrated care approach, yet 
continue to refer most of their patients only when no further oncologic treatment is possible, or at the end of life 4.   
Despite positive attitudes towards PC, barriers co-exist, and the late introduction of PC is concerning and discordant 
with current evidence which indicates a combined model of care needs to be integrated earlier in the trajectory of 
disease for PC to have meaningful influence on patients' quality of life and medical care 5.  
 
There is little research exploring the interface of oncology and PC and no study has investigated referral practices in 
Ireland 6. The primary aim of this research was to obtain insight and accurate descriptive data regarding oncologist 
attitudes and clinical practice regarding the management of patients with advanced cancer. Our objective was to 
identify obstacles which may delay or prevent the appropriate referral of patients with advanced cancer to PC. This 
information will facilitate the optimal integration of PC in Irish cancer care, ensuring a comprehensive and robust 




This was a quantitative cross-sectional design that looked at a study population of doctors practicing in four medical 
specialties: medical oncology, radiation oncology, haemato-oncology and palliative medicine in the Republic of 
Ireland. Inclusion criteria included training at registrar, specialist registrar and consultant level. Different surveys 
were circulated to oncologists and PC physicians.  
 
The questionnaires were devised based on a validated survey tool conducted by the European Society of Medical 
Oncology (ESMO) Taskforce on Palliative and Supportive Care and included items adapted from Bradley’s Caring for 
Terminally Ill Patients: Physician Survey 7, 8. An online and anonymous 85-item questionnaire collected demographics 
and data on participants’ referral practice, direct involvement and collaboration in PC including attitudinal and 
perceptual items regarding potential barriers and triggers surrounding PC referral.  
Ethical approval was received from the Research Ethics Committee of Cork Teaching Hospitals (CREC). Consent was 




The study (N = 100) comprised of 69% oncologist (43 medical oncologists, 15 radiation oncologists and 11 haemato-
oncologists) and 31% (N = 31) PC participants. The umbrella term of oncologist will herein include medical 
oncologists, radiation oncologists and haemato-oncologists. 
 
Ninety-five (95%) respondents practice in a regional cancer centre or hospice. The largest portion of our participants 
identified as consultant (57%). Most of the responding palliative medicine physicians were female (68% N = 21) while 
there was greater gender balance in oncology participants (female: 51% N = 35 and male: 49% N = 33). The median 
respondent age was 40 - 44 years. Overall most oncologist respondents were very involved in the care of patients 
with advanced cancer: 58% of oncologists reported that the management of patients with advanced cancer 
represented a substantial portion (> 50%) of their practice, while few (9%) reported that patients with advanced 
disease represented < 25% of their practice. 
 
Collaboration 
To gain insight into current oncology clinical practice and the degree to which oncologists collaborate with PC 
services participants were asked “In your dealings with patients with advanced cancer, how often do you collaborate 
with” on a 5-point Likert-type scale.  
 
Table 1: Frequency (percent) of oncologist collaboration with other professionals when managing patients with advanced 
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PC nurse 100 (69) 46 (31) 38 (26) 13 (9) 3 (2) 2.2 
PC doctor 100 (69) 36 (25) 46 (32) 16 (11) 1 (1) 2.3 
Social worker 100 (69) 13 (9) 55 (38) 16 (11) 16 (11) 1.1 
Psych-oncology 100 (69) 3 (2) 46 (32) 20 (14) 30 (21) 1.2 
Home care team 100 (69) 3 (2) 33 (23) 30 (21) 33 (23) 1.7 
Inpatient hospice 100 (69) 1 (1) 20 (14) 33 (23) 45 (31) 0.8 
Direct Involvement 
To evaluate oncologist’s direct involvement in managing patients with advanced cancer we explored their clinical 
practice activities. For comparison, we asked the PC physicians the same questions (15 items).  
 
Noteworthy findings include 61% of PC physicians reported direct involvement in managing the complications of 
chemotherapy every day - indicating that a large proportion of their patients are concurrently on active disease 
modifying treatment. In contrast 12% of oncologists describe directly administering end-of-life (EOL) care on a daily 
basis, denoting a high level of oncologist involvement in end-stage disease management for their actively dying 
cancer patients.  
 
Figure 1: Comparison of frequency (percent) of daily/weekly administration of end-of-life (EOL) care between oncologist and 
palliative care physicians.  
 
Questions surrounding daily activities and the concordance in responses displayed in figure two highlights the 
enormous clinical overlap and shared care goals which may go unrecognised in clinical practice. Both specialties are 
dealing with the same patient symptoms: the complex care needs of patients with advanced cancer are not the 
exclusive domain of oncology or PC. 
Figure 2: Frequency (percent) of daily direct administration of care for patients with advanced cancer: a comparison between 



























All cancer centres should have a palliative care service 99 
I derive satisfaction from managing the physical symptoms of my patients  97 
I have a close working relationship with the PC services in my region  96 
All advanced cancer patients should receive concurrent PC, even if they are receiving anti-tumour 
therapies 
90 
A PC specialist is the best person to co-ordinate PC for advanced cancer patient.  87 
I derive satisfaction from managing advanced cancer and dying patients  84 
Oncologists should be expert in the management of physical and psychological symptoms of 
advanced cancer  
83 
I am interested in participating in research in PC treatment of advanced cancer  81 





To our knowledge this is the first study assessing aspects surrounding the referral of oncology patients to PC services 
in Ireland. Our research examined the degree to which oncologists are directly involved in the management of 
patients with advanced cancer, the level of cross-specialty collaboration, oncologist attitudes of palliative care and 
explored barriers that might delay or prevent the timely and appropriate referral of oncology patients with PC needs 
to the relevant services.  
 
Several clinically relevant themes emerged providing accurate descriptive data and insight into referral practice and 
attitudes in relation to management of cancer: oncologists agreed that patients’ and families’ needs are better met 
with access to PC services, patients can benefit from simultaneous oncologic treatment and PC, and that early 
referral to PC services is optimal. Oncologists recognised the role of PC services, especially PC nurses supporting 
them in the care of cancer patients and as a valued connection to PC doctors. 
 
While oncologists reported being satisfied with PC services, clinicians with a positive attitude toward the role of the 
PC are much more likely to refer patients, incorporate care and collaborate with PC services. However, we found 
that acknowledged benefits of early PC referrals were at times inconsistent with practice: oncologists endorsed the 
belief that advanced cancer patients should receive concurrent treatment, however referral rates on diagnosis are 
suboptimal and oncologists regularly administer end-of-life care despite agreeing PC specialists should coordinate 
palliation.  
This mismatch in accepted benefit versus actual practice must also be attributed to the existing structure and 
capacity of the healthcare system. The current healthcare system is not configured for coordinated care: The 
National Doctors Training and Planning review of the palliative medicine workforce in Ireland highlighted that there 
are not enough PC doctors working in acute hospitals. Oncologists recognise that the strained PC services cannot 
cope, and they intercede to fulfil the role 9.  
Low levels of oncologists reporting daily direct involvement in managing psychological complications of cancer 
(depression and anxiety) compared to PC physicians may also indicate a psychology service-need for patients.  
 
It will be essential to address these factors in order to ensure the successful implementation the National Cancer 
Control Programme (NCCP) established in 2007 to formulate a whole population, integrated and cohesive approach 
to cancer 10. All of these developments have delivered continuing improvements in outcomes for Irish patients with 
cancer. Recommendation 31 of the NCCP Cancer Strategy 2017-2026:  
Designated cancer centres will have a sufficient complement of specialist palliative care professionals, including 
psycho-oncologists, to meet the needs of patients and families (such services will be developed on a phased basis to 
be available over seven days a week) 10. 
This was a novel study on physician perspective building upon previous peer led and IMJ published research which 
examined patient attitudes - patients deemed PC beneficial but a significant relationship exists between familiarity 
with PC and thinking it’s only offered “when nothing more can be done” 6. Extrapolating this to our research it is 
possible that even patients who agree with their oncologist to a PC referral may not ultimately allow the PC team 
access, for whatever reason, and this may explain some discrepancies in oncologist positive attitudes towards to PC 
yet their level of involvement in end of life care.  
We estimate the overall our survey response rate was approximately 70%. This is higher than comparable research 
for a national survey of these professional groups, yet it raises the possibility of responder bias. If we assume that 
responders had a positive bias towards palliative care compared to non-responders, then real referral practices are 
likely to be less than our results suggest, and positive attitudes overstated.  
 
95% of respondents practice in a regional cancer centre or hospice and a total of 12 counties from each province in 
the Republic of Ireland were represented, however there may be geographic, regional or administrative 
impediments to early referral. The role of the GP may be very significant in some regions - this was not examined in 
our work and warrants further exploration. 
 
Regarding survey design, the PC consultant group highlighted an inadequate feedback mechanism which limited 
their opportunity to provide extra information. A text box after each question could perhaps have generated a 
deeper understanding of physician attitudes.  
An inherent strength of this study was the collaborative effort between oncology and PC: research co-operation 
leads to mutual understanding, better clinical teamwork and ultimately comprehensive care for patients. Other 
strengths include: the pilot of our surveys, a response rate representative of the population and high level of 
consultant participation.  
 
Our study demonstrated the willingness between oncologists and PC teams to work together to meet the needs of 
patients. We highlighted the shared desire to provide PC in the acute hospital setting. The gulf between widely 
expressed positive attitudes and limited implementation suggests the need for better structured specialist training 
schemes, more PC doctors, and infrastructural changes to facilitate better actualisation of PC in clinical practice in 
Ireland.  
The findings suggest that service development is needed to make room in our current system to adopt initiatives 
such as those used in the Temel trial and in achieving the actualisation of the vision of the National Cancer Strategy 
by 2026. Multiple models of PC integration in oncology, such as co-ordinated clinics, have been proposed: while no 
one model exists as a paradigm for all, collaborative oncology and palliative care is a clinically meaningful and 
feasible care model with established evidence that it positively impacts patient outcomes and improves quality of 
life 1 - 3 .  
Oncology and PC are not mutually exclusive: the availability of and successful integration of early PC into cancer care 
could prove significant in defining further treatment guidelines for cancer care in Ireland. 
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